Halofuginone can worsen liver fibrosis in bile duct obstructed rats.

Liver Int

Deparment of Hepatology, University Hospital Gasthuisbergs, Catholic University of Leuven, B-3000 Leuven, Belgium.

Published: October 2004

AI Article Synopsis

  • Halofuginone (HF), an antifibrotic agent, has not shown beneficial effects on biliary liver fibrosis in rats, unlike its effects on other models of liver fibrosis.
  • In a study, bile duct-obstructed rats treated with HF exhibited worse aminopyrine breath test results and higher biliary fibrosis scores compared to untreated rats.
  • Findings suggest that HF might exacerbate biliary fibrosis and highlight the need for caution in using HF for chronic conditions involving cholestasis in humans.

Article Abstract

Background/aims: Halofuginone (HF) is an antifibrotic agent in rat models of liver fibrosis caused by repetitive intoxications. A beneficial effect of HF on a biliary type of liver fibrosis has not been proven yet.

Methods: Bile duct-obstructed rats were given HF from the moment of obstruction onwards and compared with no treatment. After 3 weeks, respectively, 6 weeks, aminopyrine breath test (ABT) and haemodynamic measurements including of portal pressure were carried out. Liver pieces were taken for Sirius red quantitative scoring, as well as for semiquantitative determinations of collagen type I and III RNA levels.

Results: ABT was significantly worse in HF-treated rats as compared with no treatment (P=0.02). Haemodynamic data and collagen type I and III determinations were not significantly different between groups. Biliary fibrosis scores were significantly higher in HF-treated rats as compared with no treatment (P=0.03). More Sirius red staining was associated with more proliferation of bile ductules.

Conclusions: HF may worsen biliary fibrosis. This contrasts sharply with antifibrotic effects in other models of liver fibrosis. Distinctive cellular mechanisms in biliary fibrosis may explain this discrepancy. One should be cautious for chronic application of HF in man with cholestasis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2004.0950.xDOI Listing

Publication Analysis

Top Keywords

liver fibrosis
16
compared treatment
12
biliary fibrosis
12
models liver
8
sirius red
8
collagen type
8
type iii
8
hf-treated rats
8
rats compared
8
fibrosis
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!